Clinical Trials Browser

Phase 2 × Myeloid Malignancy × 90 days × Clear all

NCT03850418 2026-02-24

Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

Phase 2 Recruiting

Myeloid Malignancy